Acceptance of coronavirus disease 2019 vaccination among postpartum women during delivery hospitalization DOI
Insaf Kouba, Yasaman Yaghoubian, Burton Rochelson

et al.

The Journal of Maternal-Fetal & Neonatal Medicine, Journal Year: 2022, Volume and Issue: 35(26), P. 10502 - 10505

Published: Oct. 9, 2022

The immediate postpartum period, during delivery hospitalization, represents a unique opportunity to offer coronavirus disease 2019 (COVID-19) vaccination those who did not previously receive it. In this study, we evaluated patient characteristics associated with acceptance of in group.This retrospective cohort study all unvaccinated patients were offered COVID-19 hospitalization between May 2021 and September at seven hospitals within large integrated health system New York. During the each hospitalized, obstetrical was vaccine prior discharge. Patients positive SARS-CoV-2 PCR testing excluded. Medical records reviewed obtain sociodemographic confirm administration vaccination. Multiple logistic regression performed model probability receiving vaccination.A total 8,281 included for analysis 412 (5%) received before hospital more likely be older, have private insurance, decline answer questions about religious affiliation, deliver final two months period. Likelihood affected by race-ethnicity, preferred language, marital status, parity, body mass index, or neighborhood socioeconomic conditions. declined antibody compared (49 vs. 29%; p < .001).Only 5% It is concerning that public insurance less This may due variation counseling other unmeasured factors. Despite low rate our population, should variety clinical settings maximize opportunities administration.

Language: Английский

Obstetric violence is a misnomer DOI Open Access
Frank A. Chervenak, Renee McLeod‐Sordjan,

Susan Pollet

et al.

American Journal of Obstetrics and Gynecology, Journal Year: 2023, Volume and Issue: 230(3), P. S1138 - S1145

Published: Oct. 6, 2023

Language: Английский

Citations

29

The impact of birth settings on pregnancy outcomes in the United States DOI Open Access
Amos Grünebaum, Eran Bornstein, Renee McLeod‐Sordjan

et al.

American Journal of Obstetrics and Gynecology, Journal Year: 2023, Volume and Issue: 228(5), P. S965 - S976

Published: March 23, 2023

Language: Английский

Citations

11

An exploration of women's decision-making processes around accepting or declining vaccinations in pregnancy: A qualitative descriptive study DOI Creative Commons

Billie Ní Riada,

Douglas M. Noonan

Midwifery, Journal Year: 2025, Volume and Issue: unknown, P. 104441 - 104441

Published: May 1, 2025

Language: Английский

Citations

0

Factors Influencing COVID-19 Vaccine Hesitancy in Pregnant and Breastfeeding/Puerperium Women: A Cross-Sectional Study DOI Creative Commons
Dania Comparcini, Marco Tomietto, Francesco Pastore

et al.

Vaccines, Journal Year: 2024, Volume and Issue: 12(7), P. 772 - 772

Published: July 14, 2024

Vaccination among pregnant and breastfeeding women is critical for protecting this vulnerable population their children. COVID-19 vaccination recommended both during pregnancy breastfeeding; however, we still do not fully understand the determinants that influence hesitancy towards vaccination. This study aimed to identify of vaccine in breastfeeding, puerperium women. A multicenter, cross-sectional study, involving 435 women, was conducted. evaluated by administering Attitudes (VAX) Scale Zung Anxiety Self-Assessment (SAS) adopted measure anxiety levels. Overall, 14% participants reported they did receive vaccine, 78.3% received first dose or while breastfeeding. The descriptive statistics VAX scale showed a total mean score 3.35 (±1.6), 75% an index equal lower than threshold. Vaccine increased as "adverse events after vaccination" (

Language: Английский

Citations

3

Cross-Sectional Survey of High-Risk Pregnant Women's Opinions on COVID-19 Vaccination DOI Creative Commons

Marcia DesJardin,

Edward Raff,

Nicholas Baranco

et al.

Women s Health Reports, Journal Year: 2022, Volume and Issue: 3(1), P. 608 - 616

Published: June 1, 2022

Background: Pregnant women are at increased risk of severe disease with coronavirus 2019 (COVID-19). Despite strong recommendations from American College Obstetricians and Gynecologists Society for Maternal Fetal Medicine vaccination, COVID-19 vaccination hesitancy persists. With this study, we aim to evaluate opinions about the vaccine in a cohort high-risk pregnant patients. Materials Methods: Institutional review board approval was obtained. Patients attending regional Maternal–Fetal clinic central New York were surveyed using standardized questionnaire. Demographic, obstetrical, medical information abstracted records. The vaccinated unvaccinated groups evaluated chi-square tests Bayesian model. Results: Among 157 participants, 38.2% vaccinated. There no significant differences race/ethnicity, living situation, marital status, employment insurance type, pregravid body mass index, history recreational drug use, number children, or gestational age time survey. less formal education likely be difference between influenza tetanus diphtheria pertussis rates rates. Unvaccinated patients cite lack data pregnancy (66%) as their primary concern. Most prefer learn vaccines via conversation doctor (46.7% 59.8% unvaccinated). Conclusions: rate is low our population. A provider-initiated included routine prenatal care could increase rate.

Language: Английский

Citations

14

Covid and pregnancy in the United States – an update as of August 2022 DOI Open Access
Amos Grünebaum,

Joachim W. Dudenhausen,

Frank A. Chervenak

et al.

Journal of Perinatal Medicine, Journal Year: 2022, Volume and Issue: 51(1), P. 34 - 38

Published: Sept. 19, 2022

Abstract COVID-19 is caused by the 2019 novel coronavirus (2019-nCoV). The first cases of were identified in December 2019, and United States (US) case was on January 20th, 2020. Since then, has spread throughout world declared a pandemic WHO March 11, As July 2022, about 90 million persons have been infected with US, there over 1 deaths There 224,587 pregnant patients COVID-19, 34,527 hospitalized. Pregnancy increases risk severe disease associated vaccinated are significantly less likely to develop disease. Adverse pregnancy neonatal outcomes more common among women SARS-CoV-2 during pregnancy, especially those disease, vaccination also protects newborn infant. intrauterine transmission appears be rare. vaccinations booster shots safe. In addition, available data suggest that antibodies fetus. lactating high levels breast milk. It important future pandemics concept vaccine recommendations should made early prevent maternal, fetal, morbidity mortality. Physicians other healthcare professionals strongly recommend who pregnant, planning become breastfeeding.

Language: Английский

Citations

14

Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic DOI Creative Commons
Dana Meaney‐Delman,

Sarah Carroll,

Kara N.D. Polen

et al.

Vaccine, Journal Year: 2024, Volume and Issue: 42, P. 125644 - 125644

Published: Feb. 29, 2024

Language: Английский

Citations

2

Pregnant individuals perspectives towards receiving COVID-19 vaccination during their pregnancy: an in-depth qualitative study DOI Creative Commons
Sanne J. M. Zilver, Anna L. Rietveld, Noralie N. Schonewille

et al.

Frontiers in Public Health, Journal Year: 2024, Volume and Issue: 12

Published: Aug. 21, 2024

Introduction Pregnant individuals have an increased risk of severe illness from coronavirus disease 2019 (COVID-19) infection. Vaccination is effective strategy to prevent and complications for pregnant individuals. are often excluded research remain hesitant receive vaccination against COVID-19. It pivotal study factors related vaccine uptake hesitancy among We studied barriers facilitators choice motivation regarding COVID-19 during pregnancy aid future in their decision vaccinate various infectious agents. Methods In this qualitative study, were interviewed between October 2021 January 2022 using a semi-structured approach. A topic list was used explore feelings, perceptions ideas pregnancy. Interviews transcribed verbatim thematic analyses performed MAX QDA. Results After nine interviews, saturation reached. Three main themes identified that influenced vaccination: health consequences, ambiguity information societal motivation. Health consequences mainly concerned the effect offspring, unknown long-term effects vaccination. The advice Dutch institute Public Environment changed not vaccinating after release developed vaccine, routinely all data available United States America (USA). This change policy fuelled doubt confusion Arguments favor social perspective specific behaviour rules restrictions due pandemic. E.g. without people unable travel abroad having take test every time entering public place. Conclusion need clear, unambiguous concerning short- long-term, particularly decision-making process Additionally, needs be addressed. Besides aforementioned themes, general counselling should focus on misperceptions safety role misinformation which also important non-pregnant population. underlines importance including programs obtain targeted needs.

Language: Английский

Citations

2

COVID-19 Vaccine Uptake and Hesitancy among Pregnant and Lactating Women in Saudi Arabia DOI Creative Commons
Hayfa A. AlHefdhi, Syed Esam Mahmood,

Manar Ahmed I. Alsaeedi

et al.

Vaccines, Journal Year: 2023, Volume and Issue: 11(2), P. 361 - 361

Published: Feb. 5, 2023

Pregnant and breastfeeding women comprise a high-risk group for the development of severe COVID-19. Therefore, vaccination is highly recommended perinatal women; however, levels this remain inadequate. This study explores percentage COVID-19 among Saudi pregnant lactating women, as well their attitudes toward it.We conducted cross-sectional questionnaire-based survey on sample women. The included women.The vaccine uptake was 78.2%. A total 45 (21.8%) out 206 did not receive vaccine. overall hesitancy 21.8%. Breastfeeding were 2.86 more likely to compared Being mother over five children increased our participating (n = 20, 90%; p < 0.01). majority subjects had taken Pfizer (81.98%, 132/161). availability most common factor choosing particular Protection from infection (60.2%, 97/161) reported main driver uptake. reason perceived delaying being worried about side effects (176, 85.44%) one's own body unborn child (130, 63.1%).We uncovered high hesitancy, primarily induced by concerns adverse social media-related misinformation. These are due large-scale obligatory program provided in Arabia, which well-structured far reaching. Our results provide further support so-called "protection motivation theory" boosting acceptance. Counseling educating need hour.

Language: Английский

Citations

6

A Sensitive Public Health Issue—The Vaccine Acceptancy and the Anti-Pertussis Immune Status of Pregnant Women from a Romanian Metropolitan Area DOI Creative Commons
Valeria Herdea,

Petruța Tarciuc,

Raluca Ghionaru

et al.

Children, Journal Year: 2023, Volume and Issue: 10(4), P. 640 - 640

Published: March 29, 2023

(1) Background: Immunization of pregnant women (PWs) against Bordetella pertussis infection is still a challenging health matter. (2) Methods: We gathered questionnaire data from 180 PWs regarding their expectancies and current opinion on infectious disease prevention. For the group who agreed to further investigations, serum levels Ig G anti-B. antibodies (IgG-PT) titer were measured analyzed. (3) Results: A total completed 98 (54.44%, study group) accepted perform laboratory tests. During first two pregnancy trimesters, found be more willing (compared with control test for identifying high-risk situations that could affect themselves future infant (p < 0.001). Most participating (91, 91.9%) had low anti-pertussis (values 40 IU/mL). Declared vaccine coverage newborn infants DTaP-1 Prevenar 13 (at 2 months) DTaP-2 4 vaccination reached 100% in group, while only 30/82 (36.59%) vaccinated during pregnancy, none them providing infants' coverage. (4) Conclusions: Enrolled faced waning immunity B. infection. By raising maternal confidence protective role vaccines diseases, better acceptance can achieved.

Language: Английский

Citations

4